Skip to main content
logo
CanSino Biologics Inc. (HKG:6185)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
33.94
+1.74 (5.40%)
At close: Mar 6, 2026

CanSino Biologics Revenue

In the year 2025, CanSino Biologics had annual revenue of 1.07B CNY with 26.18% growth. CanSino Biologics had revenue of 375.34M in the quarter ending December 31, 2025, with 34.40% growth.

Revenue
1.07B CNY
Revenue Growth
+26.18%
P/S Ratio
11.62
Revenue / Employee
957.76K CNY
Employees
1,115
Market Cap
13.81B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.07B221.57M26.18%
Dec 31, 2024846.34M489.25M137.01%
Dec 31, 2023357.08M-677.51M-65.49%
Dec 31, 20221.03B-3.27B-75.94%
Dec 31, 20214.30B4.27B17,174.82%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
China Traditional Chinese Medicine Holdings Co.17.08B
Shandong Xinhua Pharmaceutical Company9.28B
Luye Pharma Group6.76B
Sunshine Lake Pharma3.96B
Consun Pharmaceutical Group3.58B
Sihuan Pharmaceutical Holdings Group2.30B
Beijing Tong Ren Tang Chinese Medicine Company1.71B
OneRobotics (Shenzhen)801.23M
Revenue Rankings

CanSino Biologics News

More News